TrialMovement disorders clinical practice2025

An Open-Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated Dystonia.

Andres Deik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.